"
Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
| Line 11: | Line 11: | ||
top:-10px; | top:-10px; | ||
width:100%; | width:100%; | ||
| - | margin-bottom:- | + | margin-bottom:-70px; |
position:relative; | position:relative; | ||
/*top:-10px;*/ | /*top:-10px;*/ | ||
| Line 177: | Line 177: | ||
<img src="https://static.igem.org/mediawiki/2013/7/7d/PB_Banner_Lines2.gif" width="1100"> | <img src="https://static.igem.org/mediawiki/2013/7/7d/PB_Banner_Lines2.gif" width="1100"> | ||
</div> | </div> | ||
| - | <img src="https://static.igem.org/mediawiki/2013/3/3a/PB_logoParis.gif" width="122px" style="position:relative;bottom: | + | <img src="https://static.igem.org/mediawiki/2013/3/3a/PB_logoParis.gif" width="122px" style="position:relative;bottom:610px;left:30px;"/> |
</div> | </div> | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
Revision as of 11:01, 3 October 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis affecting millions of people over the world. Using Escherichia coli as a model organism we are developing different approaches that could contribute to the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
Infiltrate macrophages with an E.coli producing TDMH, an enzyme that will lyse the Mycobacteria cell wall.
Our results here
Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
team2013@igem-paris.org
+33 1 44 41 25 22/25
team2013@igem-paris.org 
